Navigation Links
New Oral Anticoagulants Markets
Date:3/25/2013

r/>6.2.7 Clinical Data on Direct Thrombin Inhibitors 113
6.2.7.1 Dabigatran 113
6.2.7.2 Clinical Data on Oral Factor Xa Inhibitors 116
6.2.8 Rivaroxaban 116
6.2.9 Apixaban 117
6.2.10 Betrixaban 117
6.2.11 Edoxaban 117
6.3 Coronary Artery Disease 117
6.3.1 Global CAD Therapeutics Market 118
6.3.2 Anticoagulation in Acute Coronary Syndrome 118
6.3.3 Antiplatelet Therapy 119
6.3.4 Antricoagulants Therapy 119
6.4 Heart Attack (Myocardial Infarction) 123
6.4.1 Global Market for CHF Pharmaceuticals 124
6.4.2 Declining Trend in the U.S. Heart Attack Rates 124
6.4.3 Cost of Cardiovascular Diseases 125
6.5 Heart Valve Replacement 125
6.5.1 Market Trends in Prosthetic Heart Valves 126
6.5.2 Market for Mechanical Heart Valves 127
6.5.3 Market for Tissue Heart Valves 127
6.5.4 Heart Valve Replacement and Anticoagulants 128
6.5.4.1 Anticoagulation Therapy in Patients with Prosthetic Heart Valves 129
6.6 Deep Vein Thrombosis (DVT) 130
6.6.1 Commonly Recognized Signs and Symptoms of DVT 131
6.6.2 Complications of VTE 131
6.6.3 Use of Risk Assessment Tools in the Diagnosis of DVT 131
6.6.4 Current Anticoagulants Treatment Modalities for DVT 132
6.6.5 Use of Xarelto 133
6.6.6 Use of Enoxaparin: Inpatient and Outpatient 133
6.6.7 Use of Fondaparinux: Inpatient 133
6.6.8 Prophylactic Interventions 134
6.7 Joint Replacement Surgery and Risk of Blood Clot Formation 135
6.7.1 Joint Replacement Surgeries in the U.S. 136
6.7.2 Hip and Knee Replacement Surgeries in OECD Countries 138
6.7.3 Global Orthopedic Industry 139
6.7.4 Hip Replacement 140
6.7.4.1 U.S. Market for Hip Replacement 140
6.7.5 Knee Replacement 141
6.7.5.1 U.S. Knee Replacement Market 141
6.7.6 Shoulder Replacement 142
6.7.6.1 Global Shoulder Replacement Market 142
6.7.7 Oral Thrombophylaxis Following Total Hip and Knee Replacement 142
6.7.7.1 Thrombophylacti
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Global Anticoagulants Industry
2. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
3. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
4. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
5. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
6. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
7. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
8. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
9. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
10. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
11. Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
(Date:1/22/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... for cardiovascular disease and overall health is pleased to provide ... and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share with ...
(Date:1/22/2015)... , Jan. 22, 2015 Increasing sophistication among enterprise ... of localization purchasing in 2015, says Moravia ... a recent study by market research firm Common Sense ... solution for their translation and localization needs. "From a ...
Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... , SAN DIEGO , July 22 Neurocrine Biosciences, Inc. ... quarter 2010 financial results after the Nasdaq market closes on Wednesday, July ... to discuss its financial results and provide a Company update Thursday morning, ... a.m. Pacific Time ). , , ...
... 22 VirtualScopics, Inc. (Nasdaq: VSCP ), ... announced today that it has been added to the ... to provide a comprehensive and unbiased barometer for the ... in the Russell Microcap Index, which remains in place ...
Cached Medicine Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results 2VirtualScopics Added to Russell Microcap Index 2VirtualScopics Added to Russell Microcap Index 3VirtualScopics Added to Russell Microcap Index 4
(Date:1/22/2015)... 23, 2015 The U.S. Pharmacopeial Convention ... Director of Clinical Pharmacy Services at North Carolina State’s ... of the 2015 Beal Award for Distinguished Volunteer Service—the ... relied on the contributions of volunteer experts to direct ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce ... ever created for kids with cancer. The Chemo Duck App, available ... filled with enjoyable games to help children of all ages living ... helps to keep kids entertained, educated and at ease while waiting ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... treat at all , , FRIDAY, March 6 (HealthDay News) -- ... complications in women, a European study finds. , Doctors use ... In this way, they gain time to allow steroids to ... mother to be transferred to a medical facility with a ...
... DENVER, March 6 Muscle Pharm is proud to announce ... be the exclusive Nutritional Supplement Sponsor of Shane Carwin."We are ... an absolute Freak, and a true specimen," said Brad Pyatt, ... the UFC, and is headed into his biggest professional fight ...
... Pharmaceuticals (NYSE: VRX ) today announced that its ... 2009 at 9:00 a.m. Eastern Time, at the Hilton Hotel ... Jersey 07078. The record date for stockholders entitled to ... Valeant , Valeant Pharmaceuticals International (NYSE: VRX ) ...
... Forest Laboratories, Inc. (NYSE: FRX ) and Cypress ... they expect to ship Savella(TM) (milnacipran HCl), a selective serotonin ... wholesalers and pharmacies by mid 2009. Savella was approved ... January 14, 2009 and was originally expected to be available ...
... FRANCISCO, Calif., March 6 Rigel Pharmaceuticals, Inc. ... Ryan Maynard, the company,s vice president and chief ... overview at the Barclays Capital Healthcare Conference in ... p.m. EDT.(Logo: http://www.newscom.com/cgi-bin/prnh/20030226/RIGLLOGO )To access the ...
... Endocare, Inc. (Nasdaq: ENDO ), an ... minimally invasive technologies used by urologists and interventional radiologists ... the fourth quarter and year ended December 31, 2008. ... in revenue compared to the fourth quarter of 2007 ...
Cached Medicine News:Health News:Safety of Labor-Delaying Drugs Questioned 2Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 2Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 3Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 4Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 5Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM) 6Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 2Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 3Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 4Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 5Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 6Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 7Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 8Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 9Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 10Health News:Endocare Reports 2008 Annual and Fourth Quarter Financial Results 11
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: